Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VBP-245 in pediatric molluscum contagiosum
NCT03077750Phase 2Completed
- Sponsor
- Veloce BioPharma
- Start
- Feb 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VBP-245 in molluscum contagiosum (MC), sponsored by Veloce BioPharma. Started Feb 2017; status: completed.
02
Drugs
VBP-245
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on NCT03077750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077750.